|
|
|
Volumn , Issue , 2009, Pages 323-337
|
|
A summary of bortezomib use in transplantation across 29 centers.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
IMMUNOGLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
LYMPHOCYTE ANTIBODY;
PROTEINASE INHIBITOR;
PYRAZINE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
FEMALE;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMAN;
IMMUNOLOGY;
KIDNEY TRANSPLANTATION;
LUNG TRANSPLANTATION;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
PLASMAPHERESIS;
SAFETY;
ADULT;
AGED;
ANTILYMPHOCYTE SERUM;
BORONIC ACIDS;
COMBINED MODALITY THERAPY;
FEMALE;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LUNG TRANSPLANTATION;
MALE;
MIDDLE AGED;
PLASMAPHERESIS;
PROTEASE INHIBITORS;
PYRAZINES;
SAFETY;
|
|
EID: 77954568083
PISSN: 08909016
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (32)
|
|
References (0)
|
